We are committed to sustainable growth in both talent and products,
and contribute to the health and well-being of humanity through continuous innovation and equitable healthcare access.
The Board is the highest authority within Fosun Pharma for the topics of "Climate Change Response" and "Environmental Management", with the ESG management system fully responsible for the supervision, decision-making, management, and implementation of relevant initiatives. Furthermore, the Group has incorporated objectives and indicators related to "Climate Change Response" and "Environmental Management" into the performance evaluation frameworks for senior management, with a weight of no less than 5%.
In 2024, our environmental investment reached RMB 110 million,with approximately RMB 22.3 million allocated to environmental facilities and around RMB 87.44 million for the operation of environmental facilities
he ISO 14001 environmental management system has covered 83% of our production-oriented subsidiaries
In 2024, by saving electricity, natural gas, and purchased steam and purchasing green electricity, we achieved a carbon emissions reduction of 20,528 tons
In 2024, our total self-generated photovoltaic power exceeded 14.58 million kWh, representing a year-on-year increase of about four times
In 2024, we purchased over 19.25 million kWh of green electricity, reducing carbon emissions by 10,332 tons through these purchases
In 2024, we saved a total of 391,000 cubic meters of water, equaling 3.71% of the total annual water consumption
*As of December 31, 2024